• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYSB2000295 精蛋白锌重组赖脯胰岛素混合注射液(50R) Injection Biological Products Supplementary Application 2020-06-22 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Filed 2020-06-24 view
JYSB1200257 精蛋白锌重组赖脯胰岛素混合注射液(25R) Injection Biological Products Supplementary Application 2012-10-31 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Certificate Issued 2014-06-23 view
JYSB2000005 度拉糖肽注射液 dulaglutide Injection Biological Products Supplementary Application 2020-01-15 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Certificate Issued 2021-01-21 view
JXHL1000225 奥氮平片 olanzapine Tablet Chemical Drugs Import Drug Application 2010-08-09 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Certificate Issued 2011-12-22 view
JYHB1800856 赖脯胰岛素注射液 insulin lispro Injection Chemical Drugs Supplementary Application 2018-07-18 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Filed 2018-07-30 view
JYHB0900798 注射用培美曲塞二钠 pemetrexed disodium Lyophilized Chemical Drugs Supplementary Application 2009-10-16 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Certificate Issued 2011-02-14 view
JYSZ1700012 精蛋白锌重组赖脯胰岛素混合注射液(50R) Injection Biological Products License Renew 2017-08-03 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Certificate Issued 2017-10-16 view
JYHB2001431 他达拉非片 tadalafil Tablet Chemical Drugs Supplementary Application 2020-08-21 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Filed 2020-09-01 view
JYSB1500191 精蛋白锌重组赖脯胰岛素混合注射液(50R) Injection Biological Products Supplementary Application 2015-06-29 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Certificate Issued 2017-02-23 view
JXSL2000046 度拉糖肽注射液 dulaglutide Injection Biological Products Import Drug Application 2020-05-11 Eli Lilly Nederland B.V. Eli Lilly Nederland BV In Review 2020-04-30 view
JYSB1100211 精蛋白锌重组赖脯胰岛素混合注射液(25R) Injection Biological Products Supplementary Application 2011-09-27 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Certificate Issued 2012-04-10 view
JYSB1800293 特立帕肽注射液 teriparatide Injection Biological Products Supplementary Application 2018-12-17 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Certificate Issued 2019-02-28 view
JYSB0900248 精蛋白锌重组赖脯胰岛素混合注射液(25R) Injection Biological Products Supplementary Application 2010-01-21 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Certificate Issued 2010-05-04 view
JYSB1800023 精蛋白锌重组赖脯胰岛素混合注射液(50R) Injection Biological Products Supplementary Application 2018-02-05 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Filed 2018-02-08 view
JYHB2002157 他达拉非片 tadalafil Tablet Chemical Drugs Supplementary Application 2020-10-27 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Filed 2020-11-16 view
JYHB1501178 赖脯胰岛素注射液 insulin lispro Injection Chemical Drugs Supplementary Application 2015-08-17 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Certificate Issued 2017-04-06 view
JYSB2000251 度拉糖肽注射液 dulaglutide Injection Biological Products Supplementary Application 2020-06-19 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Filed 2020-06-22 view
JYHB1201196 赖脯胰岛素注射液 insulin lispro Injection Chemical Drugs Supplementary Application 2012-10-31 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Certificate Issued 2014-08-21 view
JYSB1900302 精蛋白锌重组赖脯胰岛素混合注射液(50R) Injection Biological Products Supplementary Application 2019-11-08 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Certificate Issued 2021-01-21 view
JYHB1000627 赖脯胰岛素注射液 insulin lispro Injection Chemical Drugs Supplementary Application 2010-07-29 Eli Lilly Nederland B.V. Eli Lilly Nederland BV Certificate Issued 2011-02-14 view